Description
Inclusion Criteria:
- * Histologically confirmed diagnosis of adenocarcinoma of the rectum
- * Clinical stage II (cT3-4, N-) or Stage III (cT any, N+) based on MRI
- * Eligible for total mesorectal excision
- * No evidence of distant metastasis
- * No prior pelvic radiation therapy
- * No prior chemotherapy
- * Age ≥18 years
Exclusion Criteria:
- * Patients unable to undergo MRI
- * Other anticancer or experimental therapy
- * Body mass index (BMI) \<18.5 kg/m2 or \>40 kg/m2
- * Serious or refractive cachexia or anorexia
- * Insulin-dependent diabetes Taking or needs to take any protein or amino acid containing nutritional supplements (e.g., Ensure®) Patients with a condition where high-fat or fatty food is contraindicated History of confirmed food allergy Active wound or skin graft that would require a significant increase in protein requirements for skin integrity and healing
Ages Eligible for Study:
18 Years to 100 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
No